UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current Approaches to Design Space Development and Regulatory Applications for Drug Products: Findings from the IQ Utilization of Design Space for Filings Working Group Survey

Pharmaceutical research, 2024-09, Vol.41 (9), p.1775-1786

2024

Volltextzugriff (PDF)

Accretion of the Earth and segregation of its core

Nature, 2006-06, Vol.441 (7095), p.825-833

2006

Volltextzugriff (PDF)

Exploring the wet granulation growth regime map – validating the boundary between nucleation and induction

Chemical engineering research & design, 2020-04, Vol.156, p.469-477

2020

Volltextzugriff (PDF)

Late Accretion on the Earliest Planetesimals Revealed by the Highly Siderophile Elements

Science (American Association for the Advancement of Science), 2012-04, Vol.336 (6077), p.72-75

2012

Volltextzugriff (PDF)

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features

Aggregate (Hoboken), 2022-08, Vol.3 (4), p.n/a

2022

Volltextzugriff (PDF)

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9514-9514

2020

Volltextzugriff (PDF)

An assessment of powder pycnometry as a means of determining granule porosity

Pharmaceutical development and technology, 2015-05, Vol.20 (3), p.257-265

2015

Volltextzugriff (PDF)

Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3004-3004

2017

Volltextzugriff (PDF)

CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3001-3001

2016

Volltextzugriff (PDF)

First-in-human evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8010-8010

2014

Volltextzugriff (PDF)

Fluid bed granulation – Process optimization

Powder technology, 2025-01, Vol.449, p.120358, Article 120358

2025

Volltextzugriff (PDF)

Power and Corruption in the Early Modern Portuguese World by Erik Lars Myrup (review)

Hispania, 2017, Vol.100 (1), p.144-145

Wade, Jonathan

2017

Volltextzugriff (PDF)

First-in-human evaluation of CO-1686, an irreversible, selective, and potent tyrosine kinase inhibitor of EGFR T790M

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2524-2524

2013

Volltextzugriff (PDF)

Formulation in a drop - Templated granulation and compaction analysis

Powder technology, 2024-04, Vol.438, p.119611, Article 119611

2024

Volltextzugriff (PDF)

Flow field analysis of a toroidal flow fluidized bed granulator

Chemical engineering research & design, 2024-08, Vol.208, p.359-368

2024

Volltextzugriff (PDF)

El secreto a voces

Bulletin of the Comediantes, 2014-07, Vol.66 (2), p.260-261

Wade, Jonathan

2014

Volltextzugriff (PDF)

Don Quixote in the Archives: Madness and Literature in Early Modern Spain by Dale Shuger (review)

Hispania, 2013-12, Vol.96 (4), p.798-799

Wade, Jonathan

2013

Volltextzugriff (PDF)

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2616-2616

2021

Volltextzugriff (PDF)

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

Journal of clinical oncology, 2020-06, Vol.38 (18_suppl), p.LBA5-LBA5

2020

Volltextzugriff (PDF)

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21682-e21682

2020

Volltextzugriff (PDF)

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS9084-TPS9084

2020

Volltextzugriff (PDF)

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9059-9059

2021

Volltextzugriff (PDF)

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9068-9068

2021

Volltextzugriff (PDF)

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20525-e20525

2017

Volltextzugriff (PDF)

1 – 25 von 569

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Nur zeigenMit Volltextzugriff

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(356)
Life Sciences & Biomedicine
(281)
Humans
(200)
Female
(104)
Male
(100)
Middle Aged
(66)
Adult
(65)
Aged
(58)
Biological And Medical Sciences
(39)
Science & Technology - Other Topics
(38)
Animals
(37)
Multidisciplinary Sciences
(36)
General & Internal Medicine
(35)
Patients
(34)
Physical Sciences
(34)
Neurosciences & Neurology
(30)
Oncology
(30)
Risk Factors
(29)
Medical Sciences
(28)
Medicine
(26)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(379)
Lippincott Journal Package
(249)
MEDLINE
(237)
Publisher's website
(195)
Ingenta
(170)
IngentaConnect Journals
(108)
Wiley Online Library Journals
(73)
JSTOR
(57)
Springer journals
(55)
Wiley Online Library Full Collection 2018
(49)
Oxford journals
(33)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(29)
Elsevier ScienceDirect Journals
(27)
Oxford Journals 2020 Medicine
(24)
Nature
(22)
Sage Journals
(20)
Project MUSE - Single Title Subscriptions
(19)
Project MUSE: Universal journals
(19)
Taylor & Francis Journals
(15)
Taylor & Francis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Current Approaches to Design Space Development and Regulatory Applications for Drug Products: Findings from the IQ Utilization of Design Space for Filings Working Group Survey

Accretion of the Earth and segregation of its core

Exploring the wet granulation growth regime map – validating the boundary between nucleation and induction

Late Accretion on the Earliest Planetesimals Revealed by the Highly Siderophile Elements

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

An assessment of powder pycnometry as a means of determining granule porosity

Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients

CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC

First-in-human evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M)

Fluid bed granulation – Process optimization

Power and Corruption in the Early Modern Portuguese World by Erik Lars Myrup (review)

First-in-human evaluation of CO-1686, an irreversible, selective, and potent tyrosine kinase inhibitor of EGFR T790M

Formulation in a drop - Templated granulation and compaction analysis

Flow field analysis of a toroidal flow fluidized bed granulator

El secreto a voces

Don Quixote in the Archives: Madness and Literature in Early Modern Spain by Dale Shuger (review)

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Aktive Filter

Suchergebnisse filtern